XT
IPSC icon

XTX Topco’s Century Therapeutics IPSC Stock Holding History

XTX Topco’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,518
Closed -$50.9K – 4416
2026
Q1 		$50.9K Buy
22,518
+7,185
+47% +$15.1K ﹤0.01% 3313
2025
Q4 		$15.3K Sell
15,333
-12,225
-44% -$7.46K ﹤0.01% 3119
2025
Q3 		$13.7K Buy
+27,558
New +$14.9K ﹤0.01% 2391
2025
Q2 		– Sell
-43,514
Closed -$20.7K – 2751
2025
Q1 		$20.7K Sell
43,514
-42,479
-49% -$31.9K ﹤0.01% 2130
2024
Q4 		$86.9K Buy
+85,993
New +$117K 0.01% 1798
2024
Q1 		– Sell
-14,177
Closed -$47.1K – 2072
2023
Q4 		$47.1K Buy
+14,177
New +$25.8K 0.01% 1242
2023
Q2 		– Sell
-30,862
Closed -$107K – 1612
2023
Q1 		$107K Buy
+30,862
New +$136K 0.02% 1087

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

XTX Topco's IPSC Position: Q2 2026 in Review

XTX Topco sold out of Century Therapeutics (IPSC) in Q2 2026, closing a stake of 22,518 shares — an estimated $50.9K sold.

XTX Topco first reported a position in IPSC in Q1 2023 and held it in 7 quarters. The position peaked at $107K in Q1 2023. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • XTX Topco reported no remaining Century Therapeutics position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 22,518 Century Therapeutics shares in Q2 2026, an estimated $50.9K.
  • XTX Topco first reported a position in Century Therapeutics in Q1 2023 and held it in 7 quarters.
  • XTX Topco's Century Therapeutics position peaked at $107K in Q1 2023.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.